top of page

Pioneeringtomorrow's therapeutics

through glycan engineering.

Our mission

The next generation of therapeutics.

DamLab_edited_edited.png
Dam.png

kyron.bio unlocks superior protein therapeutics by harnessing the power of glycan modifications.

Our novel engineering strategy precisely controls glycosylation patterns, opening a new era of antibody therapeutics.

This has the power to deliver better therapies and transform patient outcomes.

Read more about 

Our people

are dedicated to revolutionising the way we make therapeutic drugs

TEAM 

ADVISORS

Screenshot 2024-05-24 at 15.44.32.png

Marine Daou

FOUNDER'S ASSOCIATE

MEng Imperial College London

  • LinkedIn
Caroline_edited_edited.png

Dr. Caroline Desmurget

RESEARCH ASSOCIATE

PhD Merck Switzerland

  • LinkedIn
Sab.png

Sabine Da Silva

EXECUTIVE ASSISTANT

BA West Chester University Pennsylvania

em.png

Dr. Emilia McLaughlin

CEO & FOUNDER

PhD Institut Pasteur Paris

Woman in Leadership (EIC)

  • LinkedIn
Marn_edited.jpg

Dr. Marina Lochhead

R&D LEAD

PostDoc Institut Curie Paris

PhD Queen's University Canada

  • LinkedIn
Dam_edited.jpg

Dr. Damien Toullec

LAB MANAGER & TECHNICIAN

PhD CNRS-CRBM Montpellier

  • LinkedIn
Screenshot 2024-05-06 at 10.19.08.png

Prof. Michael Ferguson

HEAD DRUG DISCOVERY UNIVERSITY OF DUNDEE

  • LinkedIn
bjorn.jpeg

Bjørn Voldborg

HEAD NATIONAL BIOLOGICS DTU

  • LinkedIn
rene_edited.jpg

Dr. René Labatut

VP SANOFI

  • LinkedIn
marie_edited_edited.jpg

Marie Moores

INDUSTRY ADVISOR

  • LinkedIn
eu.png
2016-19-12-innovup-header-removebg-preview_edited.png
bpi_edited.png
ilab_edited.png
genio.png
Ef.png
pcup.png
neighb.png

Proudly supported by

We would love to hear from you

and leading angel investors.

News

Screenshot 2024-10-09 at 11_edited.jpg

kyron.bio is proud to share that our CEO has been selected as a Women in Leadership Program by the European Innovation Council (EIC). This exceptional opportunity provides access to world-class mentorship, strategic leadership coaching, and a strong network of industry professionals, reinforcing our commitment to innovation and empowering women in leadership.

kyron.bio selected for EIC Woman in Leadership Programme

Screenshot 2024-10-09 at 14.12.20.png

2024

Screenshot 2024-10-09 at 11_edited.jpg

kyron.bio selected for CDL program

kyron.bio is proud to be one of the 20 startups selected for the Creative Destruction Lab (CDL) program. CDL is a nonprofit organization that delivers an objectives-based program for massively scalable, seed-stage, science- companies. Each year, the Berlin program selects 20 of the best Health companies in Europe providing access to top mentors such as the Managing Director of BioNTech & Global Head of Strategic Partnerships, Novartis.

Screenshot 2024-10-08 at 13.47.49.png

2024

Screenshot 2024-10-09 at 11_edited.jpg

Caroline Desmurget joins the team as Cell Line Engineer

Caroline Desmurget has joined the kyron.bio team! Caroline has seven years of experience at Merck, where she has honed her expertise in cell line development and the optimisation of therapeutic production. Caroline will be taking care of the health and productivity of our cell lines as we continue to scale our bioproduction capabilities in house.

Caro_edited_edited.jpg

2024

Screenshot 2024-10-09 at 11_edited.jpg

kyron.bio wins the Servier Spartners Golden Ticket

kyron.bio is honoured to be the recipient of the first Golden Ticket from Servier & Spartners BioLabs, providing a year of free lab space on the Servier site and access to key mentorship from the Servier team. We are delighted to be growing our company with the support of one of the most influential players in the French ecosystem!

goldenticket_edited_edited.jpg

2024

Screenshot 2024-10-09 at 11_edited.jpg

kyron.bio is proud to win the the iLab ‘Concours d’innovation’ by Bpifrance, which focuses on supporting high-potential, innovative startups working on disruptive projects. kyron.bio is honoured to be among the 23% of women-led projects awarded this highly competitive grant, receiving €360K to support internal R&D and expedite the development of its cutting-edge glycan engineering strategy.

Screenshot 2024-10-09 at 11_edited.jpg

Women TechEU is a competitive initiative funded by the European Commission designed to support female-led European deeptech startups. As a laureate, kyron.bio was awarded €75K to develop its innovative cell line engineering approach and the program provides a strong network of inspiring female leaders.

kyron.bio selected for the Women Tech EU grant

Screenshot 2024-10-10 at 16.22.32.png

2023

2023

Screenshot 2024-10-09 at 11_edited.jpg

kyron.bio attends

Bio-Europe 2024

kyron.bio is excited to be attending Bio-Europe 2024, a global partnering conference where the world’s lifescience ecosystem meets to propel dealmaking and innovation. Our CEO will be joining some of the biggest names in the game in Stockholm, and is looking forward to connect, exchange insights, and explore potential collaborations!

Screenshot 2024-11-04 at 16_edited_edite

2024

Screenshot 2024-10-09 at 11_edited.jpg

kyron.bio attends

PEGS 2024

kyron.bio attends the PEGS Europe 2024 conference in Barcelona, alongside 1500+ protein & antibody engineering innovators! Our R&D lead, Marina Lochhead attends, having this opportunity to connect with top experts in the field, staying at the forefront of emerging trends and engaging in trailblazing discussions.

Screenshot 2024-11-06 at 12.38.20.png

2024

Screenshot 2024-10-09 at 14.46.22.png

kyron.bio wins 2023 iLab concours d'innovation 

Screenshot 2024-10-09 at 11_edited.jpg

kyron.bio selected

as Deep Tech Pioneer

kyron.bio is proud to have been selected as Deep Tech Pioneer by Hello Tomorrow out of thousands of applicants! This recognition puts our technology at the forefront of game-changing deep-tech solutions. We’re looking forward to attend the Hello Tomorrow Global Summit, March 2025, and connect with the world’s top innovators, industry leaders and investors.

Screenshot 2024-11-26 at 12.00.11.png

2024

bottom of page